Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 145 days ( -76.07 % )
Last Price $39.95 0 %
High/ Low $39.95 - $39.95 0%
Chg 7 Days N/A $39.95 $39.95
Chg 30 Days N/A $39.95 $39.95
Chg 12 mos 96.41 % $20.34 $39.95
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 121.82 % Width: 36.37 %
Pred. range - 3 mos $39.95 - $39.95 0 % - 0 %
Pred. range - 12 mos $80.14 - $109.29 100.61 % - 173.57 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Mar 21, 2023 - 139 days
Long MA avg 12 mos Buy Feb 28, 2023 - 154 days
Short/Long MA avg 12 mos Buy Jan 30, 2023 - 174 days
Pivot Short Sell Oct 06, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About IVERIC bio Inc.

IVERIC bio. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degenera... ISEE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT